BioAge Labs website screenshot

BioAge Labs

BioAge Labs (Nasdaq ticker BIOA) is a clinical-stage biopharmaceutical company based in Emeryville, California, developing therapies that target the biology of human aging to treat metabolic diseases such as obesity and its related conditions. Its proprietary discovery platform mines longitudinal human multi-omics data to identify aging-related molecular pathways, which feed a therapeutic pipeline that includes BGE-102, an oral NLRP3 inhibitor aimed at chronic inflammation and cardiovascular risk, and an APJ (apelin receptor) agonist developed as an exercise mimetic for obesity. The company is backed by a16z and Redpoint Ventures and was added to the API Evangelist network as a portfolio-company profile. BioAge Labs publishes no public developer API, documentation, or SDK surface at this time; this profile captures its corporate and web-property identity plus a domain-security probe of its primary web host.

BioAge Labs is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Longevity, and Aging.

BioAge Labs’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsLongevityAgingMetabolic DiseaseDrug DiscoveryObesityHealthcareMulti-omics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/bioage-labs: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Bioage Labs Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: bioage-labs
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/bioage-labs.png
name: BioAge Labs
description: BioAge Labs (Nasdaq ticker BIOA) is a clinical-stage biopharmaceutical company based in Emeryville, California,
  developing therapies that target the biology of human aging to treat metabolic diseases such as obesity and its related
  conditions. Its proprietary discovery platform mines longitudinal human multi-omics data to identify aging-related molecular
  pathways, which feed a therapeutic pipeline that includes BGE-102, an oral NLRP3 inhibitor aimed at chronic inflammation
  and cardiovascular risk, and an APJ (apelin receptor) agonist developed as an exercise mimetic for obesity. The company
  is backed by a16z and Redpoint Ventures and was added to the API Evangelist network as a portfolio-company profile. BioAge
  Labs publishes no public developer API, documentation, or SDK surface at this time; this profile captures its corporate
  and web-property identity plus a domain-security probe of its primary web host.
url: https://raw.githubusercontent.com/api-evangelist/bioage-labs/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- redpoint-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Longevity
- Aging
- Metabolic Disease
- Drug Discovery
- Obesity
- Healthcare
- Multi-omics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/bioage-labs-domain-security.yml
- type: Website
  url: https://bioagelabs.com/
- type: PrivacyPolicy
  url: https://bioagelabs.com/privacy-policy
- type: Blog
  url: https://ir.bioagelabs.com/news-events/press-releases
- type: LinkedIn
  url: https://www.linkedin.com/company/bioage-labs/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence